Showing results (231-240 of 366) with videos related to

Sort By:
Pageof 37
Molecular Cancer Therapeutics|September 16, 2008
Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901Julius Leyton, Graham Smith, Mark Lees, et al.
Oncogene|March 26, 2019
Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancerPaul A Clarke, Toby Roe, Kate Swabey, et al.
Nucleic Acids Research|November 18, 2024
The Chemical Probes Portal - 2024: update on this public resource to support best-practice selection and use of small molecules in biomedical researchDomenico Sanfelice, Albert A Antolin, Alisa Crisp, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
3-(5-Chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Mandy Beswick, et al.
Gynecologic Oncology|December 22, 2007
Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action/HHMT Forum, Lake Como, March 2007Alan Ashworth, Frances Balkwill, Robert C Bast, et al.
Oncotarget|June 19, 2017
Pediatric and adult glioblastoma radiosensitization induced by PI3K/mTOR inhibition causes early metabolic alterations detected by nuclear magnetic resonance spectroscopyAlice Agliano, Geetha Balarajah, Daniela M Ciobota, et al.
Molecular Cancer Therapeutics|July 5, 2006
Preclinical pharmacokinetics and metabolism of a novel diaryl pyrazole resorcinol series of heat shock protein 90 inhibitorsNicola F Smith, Angela Hayes, Karen James, et al.
Molecular Cancer Therapeutics|March 17, 2007
A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylationAnthea Hardcastle, Peter Tomlin, Clair Norris, et al.
ACS Chemical Biology|February 25, 2009
Structural basis of the radicicol resistance displayed by a fungal hsp90Chrisostomos Prodromou, James M Nuttall, Stefan H Millson, et al.
Scientific Reports|September 30, 2020
Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approachesJohn F Darby, Lewis R Vidler, Peter J Simpson, et al.
Pageof 37